1. Introduction
===============

Epidural analgesia is a common pain relief technique during labor and is popular with the parturients. The low dose of ropivacaine is widely used for epidural analgesia during labor with less adverse events.^\[[@R1]--[@R3]\]^ However, most of studies on labor analgesia are relation with the primiparas.^\[[@R4]--[@R6]\]^ So far as we know, the studies on analgesic requirements are fewer in multiparas. We investigated and compared the effective concentrations of epidural ropivacaine for labor analgesia in multiparas and primiparas.

2. Methods
==========

The ethics committee of Jiaxing University Women\'s and Children\'s Hospital approved the study (Chairman Prof Liu) on June 1, 2018, and a written informed consent was signed by all parturients. The trial was registered prior to patient enrollment at [www.chictr.org.cn](http://www.chictr.org.cn/) (ChiCTR-1800016486). Sixty-two full-term singleton women aged 20 to 35 years were included in this single-blind study. Exclusion criteria were as follows: patients with the severe cardiopulmonary disease, cervical dilatation \>3 cm, height \<150 cm or \>175 cm, induced labor, contraindications to epidural block and patients undergoing cesarean section or epidural analgesia. At last, 30 multiparas were assigned to the multipara group (Group M), and 30 primiparas were assigned to the primipara group (Group P).

Upon arrival in delivery room, vital signs including noninvasive arterial blood pressure (BP), heart rate (HR), and pulse oxygen saturation (SpO~2~) were monitored at 5-minute intervals for women. After venous access was established, Ringer\'s solutions were infused at a rate of 2 mL/kg/h. Parturients were positioned in the left lateral position, the epidural puncture was performed at the estimated level of L~2~-L~3~ interspace with an 18-G epidural needle using loss of resistance to air technique when cervical dilation was about 2 cm. Subsequently, an epidural catheter was inserted 4 cm cephalad into epidural space and patients were turned supine. Three milliliters of 1.5% lidocaine was given as a test dose to exclude the epidural catheter in the subarachnoid space, then 10 mL of mixed solutions (ropivacaine + 2 μg/mL fentanyl) was given as loading dose. The initial concentration of ropivacaine was set as 0.1% with concentration adjustment interval of 0.01%. The concentration of ropivacaine in the next patient was decided by the analgesic effect of the last patient. Effective analgesia was defined as the visual analog scores (VASs) ≤3 within 30 minutes after epidural administration. If analgesic effect of the last woman was adequate, the concentration of ropivacaine for the next woman was decreased by 0.01% interval. If analgesic effect of the last woman was inadequate, the concentration of ropivacaine for the next patient was increased at 0.01% interval. The analgesic solutions consisting of 0.1% ropivacaine and 2 μg/mL fentanyl were started continuous infusion 30 minutes after epidural injection with a patient-controlled analgesia pump (background dose of 6 mL/h, lockout time intervals of 20 minutes and a bolus dose of 6 mL). A bolus dose was administrated when VSA \>7 in both groups. Additional 10 mL of 1% lidocaine was administrated to rescue if VAS was \>4 within 30 minutes after epidural administration, otherwise, excluded from this study.

2.1. Measurements
-----------------

The BP, HR, SpO~2~, duration of labor stages, and Apgar scores were recorded. The maximum block level of sensation was measured using alcohol cotton at 1-minute interval. Umbilical artery blood gas was analyzed immediately after delivery. The analgesic effect was evaluated after epidural administration using VAS (0 = no pain, 10 = maximum pain). Motor block was assessed using Bromage scale (0 = no motor block, 1 = unable to move hip, 2 = unable to move hip and knee, 3 = unable to move hip, knee, and ankle). The adverse events such as hypotension, pruritus, nausea, and vomiting were noted. Respiratory depression was defined as SpO~2~ \<91% lasting for 30 seconds without inhaling oxygen and respiratory rate \<10 breaths/minute. The hypotension was defined as a systolic BP was below 80% of the baseline value.

2.2. Statistical analysis
-------------------------

The VAS value within 30 minutes after epidural analgesia was the primary outcome. As 6 pairs of reversal of sequence were achieved using an up and down method,^\[[@R7]\]^ Twenty-two cases of patients in each group were need in this study and 30 patients were enrolled to allow for dropouts. Numerical variables were presented as mean and standard deviation. Categorical variables were presented as numbers. Parameters distributed normally were analyzed using *t* test and parameters non-normally distributed were analyzed using nonparametric Mann--Whitney *U* test. Categorical parameters were analyzed using the Chi-squared test. A *P* \< .05 was considered as significant difference.

3. Results
==========

The flow diagram of study is shown in Figure [1](#F1){ref-type="fig"}. A total of 62 parturients were enrolled in this clinical study and 59 women finished the study, 2 women were excluded from this study for cervical dilatation \>3 cm and 1 woman was excluded for cesarean section. There were no significant differences in characteristics of the parturients between the 2 groups (Table [1](#T1){ref-type="table"}).

![The flow diagram of study.](medi-99-e18673-g001){#F1}

###### 

Characteristics of parturients.
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The characteristics of effective epidural analgesia are presented in Table [2](#T2){ref-type="table"}. Rescue bolus was greater in multipara group than those in primipara group (*P* \< .01). The onset time of analgesia and maximum level of sensory block were similar between the 2 groups (*P* \> .05). All Bromage score values were below 1 in both groups and no motor block was observed. There were no significant differences in terms of the delivery modes, Apgar scores, and umbilical arterial pH immediately after delivery between the 2 groups (*P* \> .05). No significant differences were observed in terms of hypotension, pruritus, nausea, and omitting between the 2 groups (Table [3](#T3){ref-type="table"}, *P* \> .05).

###### 

Data of parturients with effective epidural analgesia.
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###### 

Adverse events of effective epidural analgesia.
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The sequential doses of epidural ropivacaine with fentanyl are shown in Figure [2](#F2){ref-type="fig"}. The median effective concentration of ropivacaine was 0.068% (95% confidence interval \[CI\], 0.063--0.072%) in multiparas, and 0.057% (95% CI, 0.051--0.064%) in primiparas. There were significant differences between the 2 groups (*P* \< .05).

![(A) The concentrations of epidural ropivacaine using the up and down method in primiparas. "●" represents an effective analgesia and "▪" represents an ineffective analgesia. (B) The concentrations of epidural ropivacaine using the up and down method in multiparas. "●" represents an effective analgesia and "▪" represents an ineffective analgesia.](medi-99-e18673-g005){#F2}

4. Discussion
=============

In this study, we found that the median effective concentration of ropivacaine with fentanyl was 0.057% (95% CI, 0.051--0.064%) in primiparas during labor analgesia and the median effective concentration of ropivacaine with fentanyl in multiparas was 0.068% (95% CI, 0.063--0.072%) in multiparas.

The median effective dose represents a dose that produces a positive effect on 50% of individual. It is decided by the up and down sequential method. The median effective concentration of epidural ropivacaine in combination with opioids has been investigated in primiparas in previous study,^\[[@R8],[@R9]\]^ but the studies on the median effective concentration of epidural ropivacaine are fewer in multiparas. The median effective concentration of ropivacaine coadministered with fentanyl 2 μg/mL was 0.057% in primiparas, while the median effective concentration of ropivacaine coadministered with fentanyl was 0.068% in multiparas in our study. Compared with the primiparas, the median effective concentration of epidural ropivacaine with fentanyl in multiparas increased obviously. The documents reported that the patients having psychogenic pain, significantly increased prevalence compared to the patients who suffered from illnesses or pain. Moreover, the patients, who suffered from psychogenic pain, were susceptible to pain.^\[[@R10],[@R11]\]^ Their findings might be to explain this problem that analgesic requirements were increased in multiparas in our study. Additionally, the increase in the median effective concentration of ropivacaine was relevant to the history of epidural analgesia in multiparas during labor. Agaram et al^\[[@R12]\]^ reported that cervical dilatation \>7 cm, a history of opioid tolerance and a previous failed epidural increased the odds ratio for inadequate pain relief by logistic regression. The odds ratio for inadequate pain relief would increase in the multiparas ever received epidural labor analgesia when receiving epidural analgesia again as opioid tolerance and a previous failed epidural analgesia or inadequate pain relief. Finally, epidural adhesion after receiving epidural analgesia would affect the analgesic effects. The median effective concentration of ropivacaine was greater in multiparas compared to the primiparas; that was to say, the analgesia demand increased in multiparas during labor analgesia as the previous pain experiences from labor in multiparas caused psychogenic pains. Some studies indicated that only 50% to 66% was effective in parturients undergoing spinal surgery during epidural labor analgesia.^\[[@R13],[@R14]\]^ Recent research was showed that the analgesic requirements hourly did not increase in parturients after spinal surgery compared with the parturients without undergoing spinal surgery, but postoperative changes of epidural space would more or less affect the analgesic effects.^\[[@R15]\]^

There are some limitations in this study. Firstly, the median effective concentration was calculated using the formula other than regression analysis, the different methods would impact the results. Secondly, some multiparas underwent epidural labor analgesia, it would affect analgesic effects. At last, further study is needed by the larger sample size.

In summary, this study indicated that the median effective concentration of ropivacaine with 2 μg/mL fentanyl for epidural labor analgesia was 0.068% (95% CI, 0.063--0.072%) and increased in multiparas compared with the primiparas.

Acknowledgments
===============

The authors thank Yinf Zhang and Changn Wei for collecting data in this study.

Author contributions
====================

**Conceptualization:** Qinghua Peng, Zeyong Yang.

**Investigation:** Wangping Zhang.

**Writing -- original draft:** Wangping Zhang, Xiaomin Wu.

Wangping Zhang orcid: 0000-0003-3546-4449.

Correction
==========

The first author\'s name first appeared incorrectly as Qinghua Qeng. It has been corrected and now appears as Qinghua Peng.

Abbreviations: ASA = American Society of Anesthesiologists, BP = blood pressure, CI = confidence interval, HR = heart rate, SpO~2~ = pulse oxygen saturation, VAS = visual analog score.

How to cite this article: Peng Q, Yang Z, Zhang W, Wu X. Comparison of median effective concentration of ropivacaine in multiparas or primiparas during epidural labor analgesia: STROBE compliant. *Medicine*. 2020;99:1(e18673).

The study was registered with the Chinese Clinical Trials Registry, registration number: ChiCTR-1800016486.

This work was supported by Shanghai Technology Bureau (18ZR1443100), Shanghai Jiao Tong University (TM201729), and Jiaxing Technology Bureau (2017AY33077).

The authors have no conflicts of interest to disclose.
